Results 21 to 30 of about 237,233 (162)

Ovarian Fibroma with Meigs Syndrome associated with Elevated CA125 - A Rare Case

open access: yesOnline Journal of Health & Allied Sciences, 2010
Postmenopausal women with solid adnexal masses, ascites and pleural effusion with elevated CA 125 are highly suggestive for malignant ovarian tumor. However in literature 28 cases Meigs syndrome (Benign ovarian tumor, ascites and right pleural effusion ...
Prasad. K. Shetty   +3 more
doaj   +2 more sources

Meigs syndrome was misdiagnosed as a malignant ovarian tumor: a case report [PDF]

open access: yesFrontiers in Oncology
BackgroundMeigs syndrome is characterized by the association of a benign ovarian tumor, typically an ovarian fibroma, with pleural effusion and ascites.Case summaryThis report presents a case of a 54-year-old woman who was misdiagnosed with malignant ...
Hongmei Li   +4 more
doaj   +2 more sources

Fibroma with minor sex cord elements – an incidental finding in a normal sized ovary A case report with literature review [PDF]

open access: yesDiagnostic Pathology, 2007
Ovarian fibroma with minor sex cord element is a rare neoplasm. Microscopically it is composed of predominantly fibromatous or a thecomatous tumor containing scattered minor sex cord elements in less than 10% of the tumor area.
Singh Meeta   +4 more
doaj   +2 more sources

Collision tumor of the ovary: Fibroma and mature cystic teratoma

open access: yesIndian Journal of Pathology and Microbiology, 2021
Collision tumor consists of two tumors occurring in the same organ without intermixture of the two cell types. The most common type of collision tumor in ovary is between teratoma and surface epithelial tumor.
Geok C Tan   +3 more
doaj   +1 more source

Ovarian Fibroma Mimicking Malignant Tumor on F-18 FDG PET/CT

open access: yes, 2022
Benign ovarian tumors like fibroma rarely shows mild or moderate F-18 FDG uptake. FDG-avid adnexial lesions in postmenopausal women should be as considered primarily malignant.
T.F. Çermik   +9 more
core   +1 more source

Apparent diffusion coefficient histogram analysis for differentiating solid ovarian tumors

open access: yesFrontiers in Oncology, 2022
ObjectiveTo evaluate the utility of apparent diffusion coefficient (ADC) histogram analysis to differentiate between three types of solid ovarian tumors: granulosa cell tumors (GCTs) of the ovary, ovarian fibromas, and high-grade serous ovarian ...
Renwei Liu   +7 more
doaj   +1 more source

Case report of bilateral ovarian fibromas associated with de novo germline variants in PTCH1 and SMARCA4

open access: yesMolecular Genetics & Genomic Medicine, 2022
Background Ovarian sex cord‐stromal tumors (OSCTs) are rare ovarian tumors that can develop from sex cord, stromal cells, or both. OSCTs can be benign or malignant.
Tomoyasu Higashimoto   +7 more
doaj   +1 more source

A midline pelvic mass: Ovarian fibroma appearing vaginal in nature.

open access: yes, 2023
INTRODUCTION: Ovarian fibroma is an uncommon, benign, stromal neoplasm that is a mixture of collagen-producing mesenchymal cells. There are varying sonographic and computed tomography features described in literature of smaller scale studies. CASE REPORT:
Polk, Stuart L   +2 more
core   +1 more source

Testicular fibroma: A case report and literature review

open access: yesUrology Annals, 2021
Sex cord-stromal tumors are the second most common testicular tumors after germ cell tumors. They account for about 2%–5% of adult testicular tumors. Most of these tumors are benign. The most common sex cord-stromal tumor is Leydig cell tumor.
Amal M Algarni   +3 more
doaj   +1 more source

Ovarian fibroma with luteinized thecal cells and minor sex cord element: A rare case report

open access: yesIndian Journal of Pathology and Microbiology, 2018
Ovarian fibroma with minor sex cord element (MSCE) is a rare tumor. The increased estrogen production due to the presence of MSCE and/or luteinized thecal cells within fibroma can be a risk factor for endometrial hyperplasia or carcinoma.
Anjali Mathur, Ankit Seth, Leela Pant
doaj   +1 more source

Home - About - Disclaimer - Privacy